BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19462299)

  • 1. Global Appraisal of Individual Needs Short Screener (GSS): psychometric properties and performance as a screening measure in adolescents.
    McDonell MG; Comtois KA; Voss WD; Morgan AH; Ries RK
    Am J Drug Alcohol Abuse; 2009; 35(3):157-60. PubMed ID: 19462299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The development and validation of the Indigenous Risk Impact Screen (IRIS): a 13-item screening instrument for alcohol and drug and mental health risk.
    Schlesinger CM; Ober C; McCarthy MM; Watson JD; Seinen A
    Drug Alcohol Rev; 2007 Mar; 26(2):109-17. PubMed ID: 17364845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for psychiatric disorders in outpatients with DSM-IV substance use disorders.
    Zimmerman M; Sheeran T; Chelminski I; Young D
    J Subst Abuse Treat; 2004 Apr; 26(3):181-8. PubMed ID: 15063911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beck Depression Inventory for depression screening in substance-abusing adolescents.
    Subramaniam G; Harrell P; Huntley E; Tracy M
    J Subst Abuse Treat; 2009 Jul; 37(1):25-31. PubMed ID: 19339144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for mental disorders in leprosy patients: comparing the internal consistency and screening properties of HADS and GHQ-12.
    Senturk V; Stewart R; Sagduyu A
    Lepr Rev; 2007 Sep; 78(3):231-42. PubMed ID: 18035774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The OADP-CDS: a brief screener for adolescent conduct disorder.
    Lewinsohn PM; Rohde P; Farrington DP
    J Am Acad Child Adolesc Psychiatry; 2000 Jul; 39(7):888-95. PubMed ID: 10892231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Choosing screening instrument and cut-point on screening instruments. A comparison of methods.
    Søgaard HJ
    Scand J Public Health; 2009 Nov; 37(8):872-80. PubMed ID: 19717573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric properties of the Swedish version of the Childhood Trauma Questionnaire-Short Form (CTQ-SF).
    Gerdner A; Allgulander C
    Nord J Psychiatry; 2009; 63(2):160-70. PubMed ID: 19021077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of the GAIN Short Screener (GSS) for internalizing, externalizing and substance use disorders and crime/violence problems among adolescents and adults.
    Dennis ML; Chan YF; Funk RR
    Am J Addict; 2006; 15 Suppl 1(Suppl 1):80-91. PubMed ID: 17182423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validity of the BPRS, the BDI and the BAI in dual diagnosis patients.
    Lykke J; Hesse M; Austin SF; Oestrich I
    Addict Behav; 2008 Feb; 33(2):292-300. PubMed ID: 17976924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does subtle screening for substance abuse work? A review of the Substance Abuse Subtle Screening Inventory (SASSI).
    Feldstein SW; Miller WR
    Addiction; 2007 Jan; 102(1):41-50. PubMed ID: 17207122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability, diagnostic efficiency, and validity of the Millon adolescent clinical inventory: examination of selected scales in psychiatrically hospitalized adolescents.
    Pinto M; Grilo CM
    Behav Res Ther; 2004 Dec; 42(12):1505-19. PubMed ID: 15500818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development, validation, and utility of internet-based, behavioral health screen for adolescents.
    Diamond G; Levy S; Bevans KB; Fein JA; Wintersteen MB; Tien A; Creed T
    Pediatrics; 2010 Jul; 126(1):e163-70. PubMed ID: 20566613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Do you think you have mental health problems?": advantages and disadvantages of a single screening question for mental disorder in substance use disorder treatment.
    Veldhuizen S; Rush B; Urbanoski K
    J Stud Alcohol Drugs; 2014 Nov; 75(6):1039-46. PubMed ID: 25343663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the GHQ-36, the GHQ-12 and the SCL-90 as psychiatric screening instruments in the Finnish population.
    Holi MM; Marttunen M; Aalberg V
    Nord J Psychiatry; 2003; 57(3):233-8. PubMed ID: 12775300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor structure and concurrent validity of the Drug Use Screening Inventory in a community adolescent sample.
    Siewert EA; Stallings MC; Hewitt JK
    Addict Behav; 2004 May; 29(3):627-38. PubMed ID: 15050681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity and specificity of a brief personality screening instrument in predicting future substance use, emotional, and behavioral problems: 18-month predictive validity of the Substance Use Risk Profile Scale.
    Castellanos-Ryan N; O'Leary-Barrett M; Sully L; Conrod P
    Alcohol Clin Exp Res; 2013 Jan; 37 Suppl 1():E281-90. PubMed ID: 22974180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for serious mental illness in populations with co-occurring substance use disorders: Performance of the K6 scale.
    Swartz JA; Lurigio AJ
    J Subst Abuse Treat; 2006 Oct; 31(3):287-96. PubMed ID: 16996391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and research utility of Spanish Teen-Addiction Severity Index (T-ASI).
    Díaz R; Castro-Fornieles J; Serrano L; González L; Calvo R; Goti J; Kaminer Y; Gual A
    Addict Behav; 2008 Jan; 33(1):188-95. PubMed ID: 17601676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive validity of common mental disorders screening questionnaire as a screening instrument in long term sickness absence.
    Søgaard HJ; Bech P
    Scand J Public Health; 2010 Jun; 38(4):375-85. PubMed ID: 19850649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.